Literature DB >> 7487093

Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines.

S Ratnam1, C Kent.   

Abstract

The effects of expression of the H-ras oncogene on phosphatidylcholine metabolism were examined in C3H10T1/2 and NIH3T3 cells expressing ras constitutively or under the control of inducible promoters. Cell lines expressing ras under the control of the mouse metallothionein promoter and the Escherichia coli lac operator/repressor system and an NIH3T3 cell line stably transfected with the ras oncogene were studied. Phosphocholine levels were elevated in the cells constitutively expressing ras and were increased 4-6 h upon induction in the inducible cell lines. Glycerophosphocholine, which is elevated five- to sixfold in constitutively transfected ras cells, did not increase at early times of induction, suggesting the absence of increased phosphatidylcholine degradation via a phospholipase A. Choline kinase activity increased within 4-6 h upon induction and correlated well with the increase in phosphocholine levels. This increase in phosphocholine levels could be prevented by the addition of hemicholinium-3, a competitive inhibitor of choline kinase. Expression of activated c-raf or v-raf also increased choline kinase activity, suggesting that the induction of choline kinase by ras is downstream of the ras/raf interaction. Long-term and short-term labeling experiments failed to detect evidence for increased phospholipase C activity. These results suggest that the increase in choline kinase activity observed in cells expressing ras is an early, integral part of ras transformation and is the main contributor to increased phosphocholine levels accompanying morphological changes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487093     DOI: 10.1006/abbi.1995.9959

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 2.  MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.

Authors:  Kristine Glunde; Lu Jiang; Siver A Moestue; Ingrid S Gribbestad
Journal:  NMR Biomed       Date:  2011-07       Impact factor: 4.044

3.  Phosphorylation of the yeast choline kinase by protein kinase C. Identification of Ser25 and Ser30 as major sites of phosphorylation.

Authors:  Mal-Gi Choi; Vladlen Kurnov; Michael C Kersting; Avula Sreenivas; George M Carman
Journal:  J Biol Chem       Date:  2005-05-25       Impact factor: 5.157

4.  Crystal structures of human choline kinase isoforms in complex with hemicholinium-3: single amino acid near the active site influences inhibitor sensitivity.

Authors:  Bum Soo Hong; Abdellah Allali-Hassani; Wolfram Tempel; Patrick J Finerty; Farrell Mackenzie; Svetoslav Dimov; Masoud Vedadi; Hee-Won Park
Journal:  J Biol Chem       Date:  2010-03-18       Impact factor: 5.157

5.  ras-Induced up-regulation of CTP:phosphocholine cytidylyltransferase α contributes to malignant transformation of intestinal epithelial cells.

Authors:  Daniel J Arsenault; Byong H Yoo; Kirill V Rosen; Neale D Ridgway
Journal:  J Biol Chem       Date:  2012-11-15       Impact factor: 5.157

6.  Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.

Authors:  Sebastian A Müller; Korbinian Holzapfel; Christof Seidl; Uwe Treiber; Bernd J Krause; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-08       Impact factor: 9.236

7.  Comparison of [¹¹C]choline ([¹¹C]CHO) and S(+)-β-methyl-[¹¹C]choline ([¹¹C]SMC) as imaging probes for prostate cancer in a PC-3 prostate cancer xenograft model.

Authors:  Sarah Marie Schwarzenböck; Jana Gertz; Michael Souvatzoglou; Jens Kurth; David Sachs; Roman Nawroth; Uwe Treiber; Tibor Schuster; Reingard Senekowitsch-Schmidtke; Markus Schwaiger; Sibylle Ilse Ziegler; Gjermund Henriksen; Hans-Jürgen Wester; Bernd Joachim Krause
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

8.  Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.

Authors:  Kshama Natarajan; Noriko Mori; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

9.  Phosphatidylcholine metabolic transformation and progression signature as a pharmacodynamic biomarker.

Authors:  Eric O Aboagye
Journal:  Oncotarget       Date:  2010-07

10.  Regulation of Akt(ser473) phosphorylation by choline kinase in breast carcinoma cells.

Authors:  Boon Tin Chua; David Gallego-Ortega; Ana Ramirez de Molina; Axel Ullrich; Juan Carlos Lacal; Julian Downward
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.